Multiple Myeloma – Multiple Myeloma New Zealand

Clinical trials

Download the ClinTrial Refer App

Learn more

Latest News

January 28, 2020News

Sanofi Partners to Develop Diagnostic Test for Multiple Myeloma Patients on Potential Therapy

Sanofi announced that it partnered with Sebia to develop a new multiple myeloma diagnostic test that will help to mitigate...

January 23, 2020News

ALCYONE Update: Adding Daratumumab to VMP Improves Survival in Transplant-Ineligible Myeloma

In patients with newly diagnosed multiple myeloma (MM) who are ineligible for high-dose chemotherapy and transplantation, adding daratumumab to bortezomib,...

January 17, 2020News

Cancer drug funding welcomed

Mark Wellington cherished the final years he spent with his wife after she was diagnosed with multiple myeloma. Now he...

January 16, 2020Newsletters

Newsletter: January 2020

Happy New Year to everybody. It was a very busy and productive year in 2019. Thanks to everyone who has...

January 14, 2020News

Myeloma NZ calls on Pharmac to make good on access deal

Myeloma New Zealand is today calling on Pharmac to make good on their proposal to widen access to blood cancer...

December 20, 2019News

Pharmac to widen treatment access for myeloma – New Zealand’s second most common blood cancer

Media Release In a move welcomed by patient advocacy group Myeloma New Zealand, drug buying agency Pharmac has proposed to...

Read latest newsletter

Every quarter we’ll post news and information in our myeloma newsletter. If you would like to join the community of patients and caregivers receiving this subscribe below.

Read past newsletters

Videos

View more videos

IMPROVING SURVIVAL

SUPPORTING PATIENTS

RAISING AWARENESS

Ask the Expert

Burden of Multiple Myeloma

Treatment resources